Lan Fong WTF
No ORCID on file
· 95 papers in corpus
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…
2007
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy. It is frequently diagnosed late and shows poor prognosis with a 5 year survival rate of 30%. New blood vessel formation (angiogenesis) and new lymphatic vessel gr…